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Background
The prevalence of obesity in the United States continues
to grow at an exponential rate. Obesity is a risk factor for
a variety of chronic conditions including diabetes, hyper-
tension, high cholesterol, stroke, heart disease, certain
cancers, and arthritis (Flegal et al 2007,). The CDC
r e l e a s e dar e p o r ti nJ u l y2 0 0 9s t a t i n gt h ec o s to fh e a l t h
care related to obesity is as high as $ 147 billion annually.
In 1998 6.5 percent of medical costs were a result of obe-
sity; in 2009, 9.1 per cent of annual medical costs were a
result of obesity-related diagnosis; in 1998 this was 6.5 per
cent. The medical costs for an obese person are 42 per
cent higher than for a person of normal weight or approxi-
mately $1,429 per year (CDC 2009).
Materials and methods
The purpose of this research is to determine the possible
medical benefits of bariatric surgery for patients with a
BMI of 35 or greater. The dataset includes 1,217 patients
of whom 42 percent are White, 40 percent are Hispanic,
7.2 percent Black, 5.6 percent Pacific Islander, and 2.5 per-
cent Other. The range of age of the patients is 18-75 years.
Four different surgical procedures were performed and
patients; and the post-operative period ranges from two to
51 months. A substantial portion of patients were mor-
bidly obese (85 percent) prior to surgery, only 15 percent
had a BMI below 40. The data gathered included whether
the patient was diagnosed and being treated for a specific
co-morbidity. The range included cardiac problems, high
cholesterol, hypertension, diabetes, incontinence, joint
problems, psychological disorders, and respiratory pro-
blems. This study focused on those co-morbidities affect-
ing the cardiovascular system, cholesterol, high blood
pressure, diabetes and respiratory. The first analysis was
completed for individuals that presented with high-choles-
terol. The second analysis was completed for individuals
that presented with diabetes. The third analysis was for
individuals presenting with hypertension. The last analysis
was for individuals presenting with respiratory disease co-
morbidities. The predictor variables of interest are initial
BMI, BMI at 12 months, and type of procedure.
Results
The results of this study show that bariatric surgery
reduces BMI; levels of obesity, and reduces the incidence
of co-morbidities. The bypass surgery was most effective
with patients achieving weight loss to a normal level.
Patients found improvement and/or resolution of pre-
existing cardiac issues, high cholesterol, high blood pres-
sure, Type 2 diabetes, and sleep apnea.
Conclusions
Medical costs attributable to obesity are almost entirely a
result of costs generated from treating the diseases that
obesity promotes, and as long as obesity prevails to the
extent that it does today, it will continue to be a significant
burden on health care. This research has found improve-
ment in the presence of co-morbidities in post-operative
bariatric surgery patients.
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